Argenta Announces Integrated Drug Discovery Collaboration with Dr. Reddy's Laboratories Ltd
Argenta announced that it has entered into a drug discovery collaboration with Dr. Reddy's Laboratories Ltd. in the area of pain and inflammation.
Argenta will apply its integrated drug discovery platform and expertise for hit-to-lead and lead optimization on multiple Dr. Reddy's discovery targets in pain and inflammation. The aim of the collaboration is to deliver high quality development candidates to support Dr. Reddy's research efforts for proprietary products.
Dr. John Montana, Managing Director of Argenta, commented: "We are excited to be working with Dr. Reddy's in identifying novel and differentiated drug candidates for multiple targets meeting unmet clinical needs in pain and inflammation".
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.